These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11768137)

  • 1. Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria.
    Luciana M; Sullivan J; Nelson CA
    Child Dev; 2001; 72(6):1637-52. PubMed ID: 11768137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
    Sharman R; Sullivan K; Young R; McGill J
    Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine monitoring in children with early and continuously treated phenylketonuria: results of an international practice survey.
    Sharman R; Sullivan KA; Young RM; McGill JJ
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S417-20. PubMed ID: 20882350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing is everything: executive functions in children exposed to elevated levels of phenylalanine.
    Antshel KM; Waisbren SE
    Neuropsychology; 2003 Jul; 17(3):458-68. PubMed ID: 12959512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
    Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
    Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary report on dopamine system reactivity in PKU: acute effects of haloperidol on neuropsychological, physiological, and neuroendocrine functions.
    Luciana M; Hanson KL; Whitley CB
    Psychopharmacology (Berl); 2004 Aug; 175(1):18-25. PubMed ID: 15024549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive symptoms in adolescents with early and continuously treated phenylketonuria: associations with phenylalanine and tyrosine levels.
    Sharman R; Sullivan K; Young RM; McGill J
    Gene; 2012 Aug; 504(2):288-91. PubMed ID: 22609065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
    Sharman R; Sullivan K; Young R; McGill J
    Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up.
    Feldmann R; Osterloh J; Onon S; Fromm J; Rutsch F; Weglage J
    Mol Genet Metab; 2019 Mar; 126(3):246-249. PubMed ID: 30598390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
    Jahja R; Huijbregts SCJ; de Sonneville LMJ; van der Meere JJ; Legemaat AM; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Neuropsychology; 2017 May; 31(4):437-447. PubMed ID: 28318283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.
    Moyle JJ; Fox AM; Arthur M; Bynevelt M; Burnett JR
    Neuropsychol Rev; 2007 Jun; 17(2):91-101. PubMed ID: 17410469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological assessment among children and adolescents with phenylketonuria and hyperphenylalaninemia and its relationship with plasma phenylalanine levels.
    González García MB; Conde-Guzon P; Alcalde Martín C; Conde-Guzon MJ; Velasco Zúñiga R
    Arch Argent Pediatr; 2017 Jun; 115(3):267-273. PubMed ID: 28504493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emotional health in early-treated adults with phenylketonuria (PKU): Relationship with cognitive abilities and blood phenylalanine.
    Palermo L; MacDonald A; Limback E; Robertson L; Howe S; Geberhiwot T; Romani C
    J Clin Exp Neuropsychol; 2020 Mar; 42(2):142-159. PubMed ID: 31790339
    [No Abstract]   [Full Text] [Related]  

  • 18. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
    Romani C; Palermo L; MacDonald A; Limback E; Hall SK; Geberhiwot T
    Neuropsychology; 2017 Mar; 31(3):242-254. PubMed ID: 28240926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum tyrosine in children with phenylketonuria and mild hyperphenylalaninemia].
    Cabalska B; Nowacka M; Laskowska-Klita T; Nowaczewska I; Zorska K; Taljański W
    Med Wieku Rozwoj; 2000; 4(1):5-12. PubMed ID: 11013857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.